MANTOAN, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 1.444
EU - Europa 1.372
AS - Asia 432
AF - Africa 17
SA - Sud America 9
OC - Oceania 4
Totale 3.278
Nazione #
US - Stati Uniti d'America 1.422
DE - Germania 296
IT - Italia 293
CN - Cina 261
AT - Austria 168
SE - Svezia 153
IE - Irlanda 137
FR - Francia 82
UA - Ucraina 79
FI - Finlandia 65
SG - Singapore 44
KR - Corea 41
JP - Giappone 27
GB - Regno Unito 26
PL - Polonia 20
CA - Canada 19
IN - India 17
SN - Senegal 16
VN - Vietnam 15
GR - Grecia 11
NL - Olanda 11
BE - Belgio 8
RU - Federazione Russa 7
ES - Italia 6
HK - Hong Kong 6
IR - Iran 5
BR - Brasile 4
AU - Australia 3
CH - Svizzera 3
PK - Pakistan 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AR - Argentina 2
PR - Porto Rico 2
TR - Turchia 2
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
CZ - Repubblica Ceca 1
GH - Ghana 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
VE - Venezuela 1
Totale 3.278
Città #
Chandler 296
Beijing 169
Vienna 168
Dublin 136
Torino 96
Ashburn 75
Nyköping 66
Jacksonville 55
Villeurbanne 53
Houston 52
Dearborn 50
Medford 48
San Mateo 43
Princeton 40
Fairfield 39
Wilmington 37
Florence 35
Ann Arbor 34
Fremont 27
Turin 27
Woodbridge 25
Redwood City 22
Singapore 19
Nürnberg 16
Warsaw 16
Cambridge 13
Milan 13
Washington 13
Boston 11
Norwalk 10
Toronto 10
Seattle 9
Hyderabad 8
Pisa 8
Dong Ket 7
Nanjing 7
Nutley 7
Boardman 6
Brussels 6
Hebei 6
Ottawa 6
Shanghai 6
Tokyo 6
Duncan 5
Rome 5
San Diego 5
Verona 5
Chennai 4
Dronten 4
Düsseldorf 4
Helsinki 4
Munich 4
Changchun 3
Chengdu 3
Guangzhou 3
Hangzhou 3
Leawood 3
Los Angeles 3
Mountain View 3
Ningbo 3
San Francesco 3
San Francisco 3
Sao Jose do Rio Preto 3
Shenyang 3
Wuhan 3
Assago 2
Baran 2
Bresso 2
Changsha 2
Cocconato 2
Collegeville 2
Edinburgh 2
Falls Church 2
Flushing 2
Hong Kong 2
Jinan 2
Karachi 2
Kunming 2
Lausanne 2
Lille 2
Manchester 2
Marseille 2
Massapequa Park 2
Monza 2
Moscow 2
Nagoya 2
Naples 2
New York 2
Odesa 2
Peabody 2
Philadelphia 2
Schifferstadt 2
Shaoxing 2
St Petersburg 2
Tianjin 2
Zhengzhou 2
Accra 1
Alba 1
Albuquerque 1
Amsterdam 1
Totale 1.941
Nome #
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 269
Highly sensitive MYD88 l265p mutation detection by droplet digital polymerase chain reaction in waldenström macroglobulinemia 189
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino 179
Front-Line Brief Chemo-Immunotherapy Rituximab (R)-FND + Rituximab Consolidation ± Rituximab Maintenance in Elderly Patients with Untreated Advanced Stage Follicular Lymphoma (FL): First Interim Analysis of a Prospective Randomized Study (ML17638) 144
Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL) 138
Rituximab-Supplemented High-Dose Sequential Chemotherapy (HDS) Has Superior Response Rate and Event-Free Survival (EFS) Compared to R-CHOP in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Results from a Multicenter Randomized GITMO Trial 119
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES 112
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 105
Characteristics of the Immunoglobulin Heavy Chain (IgH) Rearrangement in Multiple Myeloma (MM): An Analysis On 308 Cases 103
Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL) 101
Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom 99
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations 97
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR 96
MYD88L265P MUTATION DETECTION IN WALDENSTRÖM MACROGLOBULINEMIA BY DROPLET DIGITAL PCR: MINIMAL RESIDUAL DISEASE MONITORING AND CHARACTERIZATION ON CIRCULATING FREE DNA 95
Immunoglobulin (Ig) Repertoire in Multiple Myeloma: High Frequency of Recurrent Aminoacid Substitutions in the FR2 and CDR2 90
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 87
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) 84
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up 77
Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial 76
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance. 74
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network. 74
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders 73
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma 72
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network 72
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 70
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome 70
null 64
Adherence of Candida albicans and Candida dubliniensis to buccal and vaginal cells. 63
Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma 57
Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms 54
Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in myeloma 51
Droplet digital PCR quantification of mantle cell lymphoma follow-up samples from four prospective trials of the european MCL network 50
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma 46
Differences in extracellular enzymatic activity between Candida dubliniensis and Candida albicans isolates. 45
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 42
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase III trial in mantle cell lymphoma 41
Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone. 39
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma 38
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network 25
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. 17
Totale 3.397
Categoria #
all - tutte 10.277
article - articoli 0
book - libri 0
conference - conferenze 3.262
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020394 0 14 7 64 30 48 61 40 33 43 33 21
2020/2021352 46 31 18 17 26 18 16 13 35 38 55 39
2021/2022535 13 12 14 39 18 18 96 27 11 63 127 97
2022/2023793 95 90 10 94 48 191 49 52 74 31 29 30
2023/2024329 62 69 27 20 28 39 7 22 1 12 8 34
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 3.397